Carlo W Cereda Selected Research

Carlo W Cereda Research Topics

13	Stroke (Strokes) 12/2022 - 08/2015
10	Ischemic Stroke 12/2022 - 05/2015
3	Atrial Fibrillation 12/2022 - 01/2021
2	Hypertension (High Blood Pressure) 05/2022 - 01/2022
2	Neurologic Manifestations (Neurological Manifestations) 10/2019 - 06/2017
1	Myocardial Infarction 12/2022
1	Leukocytosis (Pleocytosis) 10/2022
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 05/2022
1	Heart Failure 01/2022
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022
1	Brain Ischemia (Cerebral Ischemia) 10/2021
1	Transient Ischemic Attack 10/2021
1	Melanoma (Melanoma, Malignant) 10/2021
1	Atherosclerosis 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Dyslipidemias (Dyslipidemia) 03/2019
1	Deglutition Disorders (Dysphagia) 01/2019
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2018
1	Hemorrhage 05/2015
1	Hematoma 05/2015

2	Biomarkers (Surrogate Marker)IBA 12/2022 - 10/2021
2	AnticoagulantsIBA 01/2022 - 01/2021
2	Cytidine Triphosphate (CTP)IBA 09/2019 - 01/2018
1	omega-Chloroacetophenone (Mace)IBA 12/2022
1	Atrial Natriuretic Factor (ANF)IBA 12/2022
1	C-Reactive ProteinIBA 10/2022
1	poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA 01/2022
1	AntigensIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 10/2021
1	Chondroitin Sulfate ProteoglycansIBA 10/2021
1	Lipoprotein(a)IBA 01/2021
1	CreatinineIBA 03/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2015

9	Therapeutics 05/2022 - 05/2015
4	Thrombectomy 01/2022 - 06/2017
1	Punctures 06/2022
1	Patient Admission (Patient Admissions) 06/2022
1	General Anesthesia 01/2022
1	Enteral Nutrition (Feeding, Tube) 01/2019
1	Gastrostomy 01/2019
1	Precision Medicine 01/2019
1	Time-to-Treatment 08/2015